Biomarkers for Alzheimer’s Disease Drug Development (Methods in Molecular Biology, 2785)
4.7 (126 items)
Limited Time SaleUS$91.85 cheaper than the new price!!
Free cash-on-delivery fees for purchases over $99
Product details
| Management number | 233612007 | Release Date | 2026/06/27 | List Price | US$61.23 | Model Number | 233612007 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. Authoritative and practical, Biomarkers for Alzheimer’s Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease. Read more
| ISBN10 | 1071637738 |
|---|---|
| ISBN13 | 978-1071637739 |
| Edition | Second Edition 2024 |
| Language | English |
| Publisher | Humana |
| Dimensions | 7 x 1 x 10 inches |
| Item Weight | 1.85 pounds |
| Print length | 359 pages |
| Publication date | March 2, 2024 |
Bestseller ranking
Rocker Arms
Customers who viewed this product also viewed
Neuroscience
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form